September 6, 2021
TB Alliance and Lupin Announce Commercial Partnership for New Therapy for Highly Drug-Resistant TB
August 19, 2021
TB Alliance Convenes Community Engagement Stakeholders to Discuss Clinical Trial Updates
During a virtual forum on August 12, 2021 speakers shared experiences and updates on engaging with communities for research and development programs July 15, 2021
Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development
The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiative (IMI), a public-private European Research & Development Consortium July 14, 2021
TB Alliance Welcomes Dr. Suvanand Sahu to the Access Advisory Committee
He will bring more than 20 years of global and country level experience in TB and a people-centered approach to his role on the committee June 29, 2021
TB Alliance Congratulates Dr. Dan Everitt on Career Transition
As Chief Medical Officer, Dr. Everitt played key role in advancing TB therapy April 15, 2021
A Persistent Shortfall in TB Research and Development Funding
Statement on 2020 G-FINDER Report March 25, 2021